Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

12.11.24	Novavax Cuts FY24 Revenue View Below Market; Stock Drops In Pre-market - Update (RTTNews)
12.11.24	Novavax Inc. Q3 Loss Decreases, Beats Estimates (RTTNews)
11.11.24	FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up (RTTNews)
16.10.24	FDA Puts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Tumbles (RTTNews)
09.10.24	Novavax Says EU Grants Marketing Authorization For Updated 2024-2025 Nuvaxovid COVID-19 Vaccine (RTTNews)
13.09.24	Novavax Says Its COVID-19 Vaccine 2024-2025 Formula Now Available At Major Pharmacies Nationwide (RTTNews)
01.09.24	Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies (RTTNews)
30.08.24	Novavax's Updated Covid-19 Vaccine Gets EUA Approval From FDA (RTTNews)
08.08.24	Novavax Q2 Miss Estimates, Updates FY24 Revenue View Below Market; Stock Dips (RTTNews)
08.08.24	Novavax Inc. Reports Climb In Q2 Bottom Line, But Misses Estimates (RTTNews)
02.07.24	Novavax Files For Authorization With Health Canada For 2024-2025 Formula COVID-19 Vaccine (RTTNews)
24.06.24	Novavax Files For Type II Variation Of Marketing Authorization With EMA For Updated COVID-19 Vaccine (RTTNews)
07.06.24	These Biotech Stocks Hit New Highs, Did You Reap The Rewards? (RTTNews)
13.05.24	Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty (RTTNews)
10.05.24	Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine (RTTNews)
10.05.24	Sanofi Strikes COVID-19 Vaccine Agreement With Novavax; To Take Minority Stake (RTTNews)
10.05.24	Novavax Inc. Q1 Loss Decreases, Beats Estimates (RTTNews)
01.04.24	Novavax Says Updated XBB.1.5 COVID-19 Vaccine Showed Robust Neutralizing Antibody Titers (RTTNews)
28.02.24	Novavax Inc. Q4 Loss decreases, but misses estimates (RTTNews)
22.02.24	Novavax, Gavi Settle Pending Arbitration Related To Vaccine Advance Purchase Agreement (RTTNews)
18.12.23	Novavax Says Taiwan Grants EUA For Nuvaxovid XBB.1.5 Dispersion For Injection COVID-19 Vaccine (RTTNews)
18.12.23	Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan (PR Newswire)
05.12.23	Novavax's Updated COVID-19 Vaccine Now Authorized in Canada (PR Newswire)
28.11.23	WHO Grants EUL For Novavax's Updated Protein-based COVID-19 Vaccine (RTTNews)
28.11.23	Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization (PR Newswire)
17.11.23	Novavax Appoints John Trizzino To Take On Newly Created Role Of President And COO (RTTNews)
17.11.23	Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities (PR Newswire)
10.11.23	Novavax to Participate in Jefferies London Healthcare Conference (PR Newswire)
09.11.23	Novavax Slashes FY23 Total Revenue Outlook - Update (RTTNews)
09.11.23	Novavax Inc. Q3 Loss decreases, beats estimates (RTTNews)
09.11.23	Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
02.11.23	Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023 (PR Newswire)
01.11.23	Novavax's Updated COVID-19 Vaccine Approved In EU (RTTNews)
31.10.23	Novavax's Updated COVID-19 Vaccine Now Approved in the EU (PR Newswire)
31.10.23	Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU (PR Newswire)
18.10.23	Novavax Gets Full Marketing Authorization Of Its Prototype COVID-19 Vaccine In The U.K. (RTTNews)
18.10.23	Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom (PR Newswire)
18.10.23	Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore (PR Newswire)
13.10.23	Novavax COVID-19 Non-mRNA Vaccines To Be Available At Major Retail Pharmacies (RTTNews)
13.10.23	Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S. (PR Newswire)
11.10.23	Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023 (PR Newswire)
10.10.23	Novavax Launches Choose to Protect™ Campaign to Educate Public About Importance of Updated COVID Vaccination this Fall (PR Newswire)
04.10.23	Novavax's Updated COVID-19 Vaccine Authorized And Recommended For Use In U.S. (RTTNews)
03.10.23	Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. (PR Newswire)
08.09.23	Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
08.09.23	Novavax to Participate in Upcoming September Conferences (PR Newswire)
22.08.23	Novavax's Protein-based COVID Vaccine Induces Broadly Neutralizing Responses Against XBB Subvariants (RTTNews)
22.08.23	Novavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6 (PR Newswire)
08.08.23	Novavax Inc. Q2 Earnings Summary (RTTNews)
08.08.23	Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG… (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus
22.11.24		Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Gewinne in New York: NASDAQ 100 präsentiert sich fester
22.11.24		Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500
22.11.24		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus

22.11.24

Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Gewinne in New York: NASDAQ 100 präsentiert sich fester

22.11.24

Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500